• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Digital Health Alert: 3 New China Regulatory Guidelines Released

Digital Health Alert: 3 New China Regulatory Guidelines Released

Friday, 25 March 2022 / Published in Medical Device, News, NMPA Registration in China

Digital Health Alert: 3 New China Regulatory Guidelines Released

On March 9, 2022, the CMDE (Center for Medical Device Evaluation) of the NMPA (National Medical Products Administration) issued the following 3 regulatory guidelines concerning digital health:

Technical review guideline for the registration of medical device software (No.9-2022)

Scope

Class II and III SaMD (Software as Medical Device) or SiMD (Software in Medical Device)

NMPA Registration of Importing Medical Device Software

The dossier submission should include, but not limited to the following:

  • Marketing approval certificate granted from the product’s country of origin and any related supporting materials.
  • Previous batch of product information submitted before the product-specific change in its country of origin, if any.
  • List out any cultural differences such as the differences in language, functionality, scope of application, etc.

Technical review guideline for the registration of artifical intelligence medical device software (No.8-2022)

Scope

Class Class II and III AI-based SaMD or AI-based SiMD

NMPA Registration of Importing AI Medical Device Software

Based on the intended use, use scenarios, and core functions of the product, the applicant should carry out risk management activities to ensure the risks, such as the differences between Chinese and foreigners in terms of ethnicity, epidemiological characteristics, clinical diagnosis and treatment norms, etc., have been reduced to an acceptable level throughout the whole product lifecycle.

Technical review guideline for the registration of medical device software for cyber security (No.7-2022)

Scope

Class II and III SaMD or SiMD with any of the following three functions:

  • Electronic data interchange
  • Remote access control
  • User access control

Cross-Border Medical Data Transfers

Important data, personal information and human genetic resource information collected and generated in China must be stored in China by law. If there is a business need to share these data to outside of China, security assessment should be carried out in accordance to the requirements and measures formulated by the Cyberspace Administration of China (CAC) in conjunction with relevant departments of the State Council.

By Julie Zhang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: AI, AI medical devices, Cyber Security, SaMD, Software, Software as Medical Device, Software in Medical Device

What you can read next

What information needs to be provided when applying for a change in the packaging specifications of in vitro diagnostic reagents?
Chinese Pharmacopoeia 2020
Chinese Pharmacopoeia 2020 edition – official English translation issued in March 2023
Public Consultation on the Inspection Guidelines for Unknown Leachables in Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP